BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND TCL1A, P56279, 8115, ENSG00000100721, TCL1 AND Prognosis
13 results:

  • 1. AID overexpression leads to aggressive murine CLL and nonimmunoglobulin mutations that mirror human neoplasms.
    Morande PE; Yan XJ; Sepulveda J; Seija N; Marquez ME; Sotelo N; Abreu C; Crispo M; Fernández-Graña G; Rego N; Bois T; Methot SP; Palacios F; Remedi V; Rai KR; Buschiazzo A; Di Noia JM; Navarrete MA; Chiorazzi N; Oppezzo P
    Blood; 2021 Jul; 138(3):246-258. PubMed ID: 34292322
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR; Konopleva M; Khoury JD; Pemmaraju N
    Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. tcl1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
    Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
    Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Loss of NFAT2 expression results in the acceleration of clonal evolution in chronic lymphocytic leukemia.
    Müller DJ; Wirths S; Fuchs AR; Märklin M; Heitmann JS; Sturm M; Haap M; Kirschniak A; Sasaki Y; Kanz L; Kopp HG; Müller MR
    J Leukoc Biol; 2019 Mar; 105(3):531-538. PubMed ID: 30556925
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinicopathological analysis of 46 cases with CD4
    Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
    Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer.
    Li H; Yan X; Liu L; Huang L; Yin M; Pan C; Zhang P; Qin H
    Biomed Pharmacother; 2017 Apr; 88():924-930. PubMed ID: 28178623
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. tcl1 expression predicts overall survival in patients with mantle cell lymphoma.
    Shin SJ; Roh J; Cha HJ; Choi YD; Kim JM; Min SK; Kim JE; Eom DW; Lee H; Kim HJ; Yoon DH; Suh C; Huh J
    Eur J Haematol; 2015 Dec; 95(6):583-94. PubMed ID: 25688912
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Aggressive B-cell lymphomas of gastrointestinal tract: a clinicopathologic analysis of 54 cases].
    Zhou J; Xia C; Shen Q; Yin H; Zhang X; Shi Q; Zhou X; Ma J
    Zhonghua Bing Li Xue Za Zhi; 2014 Jan; 43(1):8-14. PubMed ID: 24713242
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face].
    Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P
    Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Blastic plasmacytoid dendritic cell neoplasms: clinico-immunohistochemical correlations in a series of 91 patients.
    Julia F; Dalle S; Duru G; Balme B; Vergier B; Ortonne N; Vignon-Pennamen MD; Costes-Martineau V; Lamant L; Dalac S; Delattre C; Déchelotte P; Courville P; Carlotti A; De Muret A; Fraitag S; Levy A; Mitchell A; Petrella T
    Am J Surg Pathol; 2014 May; 38(5):673-80. PubMed ID: 24441662
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?
    Rosenquist R; Cortese D; Bhoi S; Mansouri L; Gunnarsson R
    Leuk Lymphoma; 2013 Nov; 54(11):2351-64. PubMed ID: 23480493
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic and therapeutic advances in blastic plasmacytoid dendritic cell neoplasm: a focus on hematopoietic cell transplantation.
    Kharfan-Dabaja MA; Lazarus HM; Nishihori T; Mahfouz RA; Hamadani M
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1006-12. PubMed ID: 23396213
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate.
    Leitenberger JJ; Berthelot CN; Polder KD; Pro B; McLaughlin P; Jones D; Duvic M
    J Am Acad Dermatol; 2008 Mar; 58(3):480-4. PubMed ID: 18280345
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.